Patient’s Name: Age/Sex: Ward/Bed No:

Medical Diagnosis: Date of Assignment:

W
CALCIUM CARONATE
INDICATION: CLASSIFICATION: ANTACID, CALCIUM SUPPLEMENT

INDICATIONS FOR USE: PREPARATION ADMINISTRATION MONITORING

□ PO, IV: Treatment and prevention of hypocalcemia. Available forms: PO route • Monitor for adverse side effects such as:

□ PO: Adjunct in the prevention of postmenopausal osteoporosis. Chewable tabs: 350, 420, 450, 500,
750, 1000, 1250 mg
□ IV: Emergency treatment of hyperkalemia and hypermagnesemia and
adjunct in cardiac arrest or calcium channel blocking agent toxicity Tabs: 500, 600, 650, 667, 1000, 1250,
1500 mg
Gum: 300, 450 500 mg
Susp: 1250 mg/5 ml
Caps: 1250 mg
Powder: 6.5 g/packet
• Administer as antacid 1 hr after meals and at bedtime  GI: Constipation, anorexia, nausea,
• Administer as supplement 1½ hr after meals and at bedtime vomiting, flatulence, diarrhea, rebound
• Administer only with regular tablets or capsules; do not give Hyperacidity, eructation
with enteric-coated tablets
 GU: Calculi, hypercalciuria
• Administer laxatives or stool softeners if constipation occurs
• Monitor Ca1 (serum, urine); Ca1 should be
8.5-10.5 mg/dl, urine Ca1 should be 150 mg day,
monitor weekly Assess for milk-alkali syndrome:
nausea, vomiting, disorientation, headache
• Assess for constipation; increase bulk in the diet
if needed

• Assess for hypercalcemia: headache, nausea,

vomiting, confusion; hypocalcemia: paresthesia,
CONTRAINDICATIONS: twitching, colic, dysrhythmias,
Chvostek’s/Trousseau’s sign
□ Hypersensitivity
• Assess those taking digoxin for toxicity
□ hypercalcemia,
• Assess those taking for abdominal pain,
□ Hyperparathyroidism
heartburn, indigestion before, after administration
□ bone tumors

□ Precautions: Precautions: Pregnancy C, breastfeeding, geriatric, fluid

restriction, decreased GI motility, GI obstruction, dehydration, renal
disease Watch out for: drug-drug interactions

• Atenolol, etidronate, phenytoin, risedronate,

ketoconazole: decreased levels of each drug

• Digoxin: increased toxicity from hypercalcemia

• QuiNIDine: increased quiNIDine levels